SCHEMBL29495802

SCHEMBL29495802

Nc1ccc(-c2cccc3c2OCCO3)c(N)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 2/20 0.43
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35
ADRB1 P08588 1/20 0.35
KDM4E B2RXH2 1/20 0.35
STIM1 Q13586 1/20 0.34
ORAI1 Q96D31 1/20 0.34
MAP4K1 Q92918 1/20 0.34
KLKB1 P03952 1/20 0.33
HRAS P01112 1/20 0.33
KRAS P01116 1/20 0.33
CHEK1 O14757 1/20 0.33
MTNR1A P48039 1/20 0.33
LMNA P02545 2/20 0.32
CRHBP P24387 2/20 0.32
CRHR2 Q13324 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HTT P42858 1/20 0.32
RPS6KB2 Q9UBS0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22969620 1.00 CHEK2 (0.43) CHEK2ITGB2ICAM1ITGALADRB1
SCHEMBL22969403 0.80 PARP1 (0.43) CHEK2MAP4K1
SCHEMBL29495954 0.80 PARP1 (0.43) CHEK2MAP4K1
SCHEMBL3072409 0.79 ITGB2 (0.55) CHEK2ITGB2ICAM1ITGALADRB1
SCHEMBL22969433 0.78 PARP1 (0.35) MAP4K1
SCHEMBL29495812 0.78 PARP1 (0.35) MAP4K1
SCHEMBL2896414 0.71 MAPT (0.51) CHEK2KDM4ELMNASMN1; SMN2
SCHEMBL4835059 0.71 CHEK2 (0.42) CHEK2ITGB2ICAM1ITGALADRB1
SCHEMBL3396590 0.69 CHEK2 (0.40) CHEK2ITGB2ICAM1ITGALADRB1
SCHEMBL21128796 0.68 MEN1 (0.41) CHEK2ITGB2ICAM1ITGALADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010328-A1 5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS Domain Therapeutics (FR) 2022-06-15 EP claimed
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 CN claimed
EP-4010328-A1 5-HETEROARYL-PYRIDIN-2-AMINE CONFOUNDS AS NEUROPEPTIDE FF RECEPTOR ANTAGONISTS Domain Therapeutics (FR) 2022-06-15 EP disclosed
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 CN disclosed